Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Tanguy Chaumette

A Monoclonal Antibody to O-Acetyl-Gd2 Ganglioside and Not to GD2 Shows Potent Anti-Tumor Activity Without Peripheral Nervous System Cross-Reactivity

PLoS ONE

Multidisciplinary

2011

English

Colonic Biopsies to Assess the Neuropathology of Parkinson's Disease and Its Relationship With Symptoms

PLoS ONE

Multidisciplinary

2010

English

Related publications

Reducing Epitope Spread During Affinity Maturation of an Anti-Ganglioside GD2 Antibody

Journal of Immunology

Allergy

Immunology

2009

English

Phase I Trial of Anti-Gd2 Monoclonal Antibody Hu3F8 Plus GM-CSF: Impact of Body Weight, Immunogenicity and Anti-Gd2 Response on Pharmacokinetics and Survival

English

Ocular Abnormalities in Patients Treated With a Novel Anti-Gd2 Monoclonal Antibody, Hu14.18K322A

English

Complement-Mediated Mechanisms in Anti-Gd2 Monoclonal Antibody Therapy of Murine Metastatic Cancer

Cancer Research

Oncology

2005

English

The Crystal Structure of a Fab Fragment to the Melanoma-Associated GD2 Ganglioside

Journal of Structural Biology

Structural Biology

1997

English

Anti-Cd105 Antibody Eliminates Tumor Microenvironment Cells and Enhances Anti-Gd2 Antibody Immunotherapy of Neuroblastoma With Activated Natural Killer Cells

Clinical Cancer Research

Cancer Research

Oncology

2019

English

Artesunate Shows Potent Anti-Tumor Activity in B-Cell Lymphoma

Journal of Hematology and Oncology

English

Long-Term Continuous Infusion of Anti-Gd2 Antibody CH14.18/CHO in Relapsed/Refractory Neuroblastoma Patients

Journal for ImmunoTherapy of Cancer

English

Anti-Gd2 Immunoliposomes for Targeted Delivery of the Survivin Inhibitor Sepantronium Bromide (YM155) to Neuroblastoma Tumor Cells

Pharmaceutical Research

Pharmaceutical Science

2018

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Tanguy Chaumette

A Monoclonal Antibody to O-Acetyl-Gd2 Ganglioside and Not to GD2 Shows Potent Anti-Tumor Activity Without Peripheral Nervous System Cross-Reactivity

Colonic Biopsies to Assess the Neuropathology of Parkinson's Disease and Its Relationship With Symptoms

Related publications

Reducing Epitope Spread During Affinity Maturation of an Anti-Ganglioside GD2 Antibody

Phase I Trial of Anti-Gd2 Monoclonal Antibody Hu3F8 Plus GM-CSF: Impact of Body Weight, Immunogenicity and Anti-Gd2 Response on Pharmacokinetics and Survival

Ocular Abnormalities in Patients Treated With a Novel Anti-Gd2 Monoclonal Antibody, Hu14.18K322A

Complement-Mediated Mechanisms in Anti-Gd2 Monoclonal Antibody Therapy of Murine Metastatic Cancer

The Crystal Structure of a Fab Fragment to the Melanoma-Associated GD2 Ganglioside

Anti-Cd105 Antibody Eliminates Tumor Microenvironment Cells and Enhances Anti-Gd2 Antibody Immunotherapy of Neuroblastoma With Activated Natural Killer Cells

Artesunate Shows Potent Anti-Tumor Activity in B-Cell Lymphoma

Long-Term Continuous Infusion of Anti-Gd2 Antibody CH14.18/CHO in Relapsed/Refractory Neuroblastoma Patients

Anti-Gd2 Immunoliposomes for Targeted Delivery of the Survivin Inhibitor Sepantronium Bromide (YM155) to Neuroblastoma Tumor Cells